Polycystic ovary syndrome
Conditions
Interventions
Case series:oral Drospirenone/Ethinyl Estradiol Tablet
Sponsors
Guangdong Women and Children Hospital
Eligibility
Sex/Gender
Female
Age
13 Years to 38 Years
Inclusion criteria
Inclusion criteria: Patients who qualified for PCOS as per the European Society of Human Reproduction and Embryology and the American Society of Reproductive Medicine at the Rotterdam Conference in 2003 were included. Additionally, patients with no contraindication to oral contraceptives, who were confident of being compliant to the drug and provided informed consent were also included.
Exclusion criteria
Exclusion criteria: Patients who are pregnant or lactating women;diagnosed with heart cerebrovascular, liver and kidney and hematopoietic system wait for serious primary disease, mental disease; diagnosed with malignant tumors, adrenal diseases or other diseases leading to organ failure;have used any hormone drugs or drugs affecting insulin secretion in the past 3 months;history of drug use for PCOS before inclusion in the study, and history of smoking and drug abuse; have poor compliance.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| weight;Height;Waistline;Hipline; | — |
Countries
China
Contacts
Public ContactLi Li
Guangdong Women and Children Hospital
Outcome results
None listed